# An exploratory fetal MRI study examining the impact of 22q11.2 microdeletion syndrome on early brain growth

## TL;DR

This study uses fetal MRI to show that 22q11.2 deletion syndrome is linked to reduced white matter volume in the fetal brain, independent of heart defects.

## Contribution

The study is the first to examine fetal brain growth in 22q11.2 deletion syndrome using MRI, distinguishing genetic effects from those of heart disease.

## Key findings

- White matter volumes were significantly reduced in 22qDS fetuses compared to healthy controls.
- No significant differences were found in other brain regions between the groups.
- White matter volume differences were larger between 22qDS and isolated CHD fetuses.

## Abstract

Improved long-term outcomes, related to advances in surgical and clinical care of infants with congenital heart disease (CHD), has shifted focus onto the accompanying and later-onset cognitive and neuropsychiatric disorders in those who also have 22q11.2 deletion syndrome (22qDS). 22qDS is itself associated with neurodevelopmental impairments and altered brain growth. However, when brain growth in 22qDS first deviates from normal is unknown, and whether impaired brain development is primarily genetics-driven or a secondary consequence of the underlying CHD remains incompletely understood.

In this small, exploratory study, we use fetal MRI to assess volumetric brain development in 22qDS by comparing fetal brain morphometry to a set of gestation and sex-matched healthy controls, and a cohort of gestation and sex-matched fetuses with the same CHD diagnoses but without 22q11.2 deletion. Structural T2-weighted fetal brain images were acquired using a 1.5T MRI scanner. MR scanner and sequence parameters were identical in all cohorts. Motion-corrected images underwent segmentation using an automated pipeline developed for fetal brain MRI. Total brain tissue volumes, volumes for four different tissue regions (cortical grey matter, white matter, deep grey matter and cerebellum), cerebrospinal fluid and total intracranial volumes were calculated.

Antenatal imaging was acquired between 29 and 35 weeks gestation. Thirty-three fetuses were included (7 22qDS; 14 isolated CHD; 12 healthy control). White matter volumes were significantly reduced in fetuses with 22qDS compared to control fetuses (p = 0.028), but not to those with CHD without 22q11.2 deletion (p = 0.09). Large effect-sizes were seen between the 22qDS and isolated CHD cohorts (DCohen = 0.81), and between the 22qDS and control cohorts (DCohen = 1.2) for white matter volumes. No significant differences were seen in volumes of other brain regions between groups.

This exploratory study expands our existing knowledge on neurodevelopmental impairments in 22qDS to the fetal period by highlighting reduced white matter volumes compared to gestation and sex-matched control fetuses during this time-period. Our findings suggest that impaired white matter growth in fetuses with both 22qDS and CHD may not be fully explained by any underlying CHD.